Fate Therapeutics
FATE
FATE
165 hedge funds and large institutions have $903M invested in Fate Therapeutics in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
25.93% more ownership
Funds ownership: 98.06% → 123.99% (+26%)
5% more funds holding
Funds holding: 157 → 165 (+8)
8% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 52
Holders
165
Holding in Top 10
3
Calls
$1.69M
Puts
$399K
Top Buyers
| 1 | +$56.6M | |
| 2 | +$45.3M | |
| 3 | +$40.9M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$18.8M |
| 5 |
Holocene Advisors
New York
|
+$18.6M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$14M | |
| 3 | -$13.7M | |
| 4 |
Two Sigma Investments
New York
|
-$9.44M |
| 5 |
CC
Casdin Capital
New York
|
-$7.67M |